Skip to content

Fighting to Preserve the Benefits of the 340B Program

Facebook page opens in new windowX page opens in new windowLinkedin page opens in new windowMail page opens in new window
RWC-340B
Ryan White Clinics for 340B Access
RWC-340B
  • Members
    • RWC-340B Members
    • Become a Member
  • Benefactors
    • Meet Our Benefactors
    • Benefactor Application
  • Expert Advice
    • Outline of Technical Assistance
    • Peer-to-Peer Mentoring
  • Advocacy
    • Get The Facts
    • TAKE ACTION
    • Congressional Advocacy
    • Regulatory Advocacy
    • State Advocacy
    • Litigation
  • Issues
    • Contract Pharmacy
    • Discriminatory Reimbursement Toolkit
    • Carve-out Toolkit
    • PrEP Toolkit
    • COVID-19 Toolkit
    • RWC-340B Key Research
  • Events
    • Conferences
  • News
  • About Us
    • RWC-340B Principles
Search:
  • Members
    • RWC-340B Members
    • Become a Member
  • Benefactors
    • Meet Our Benefactors
    • Benefactor Application
  • Expert Advice
    • Outline of Technical Assistance
    • Peer-to-Peer Mentoring
  • Advocacy
    • Get The Facts
    • TAKE ACTION
    • Congressional Advocacy
    • Regulatory Advocacy
    • State Advocacy
    • Litigation
  • Issues
    • Contract Pharmacy
    • Discriminatory Reimbursement Toolkit
    • Carve-out Toolkit
    • PrEP Toolkit
    • COVID-19 Toolkit
    • RWC-340B Key Research
  • Events
    • Conferences
  • News
  • About Us
    • RWC-340B Principles

HRSA Administrator Thomas J. Engels Issues Dear Colleague Letter to RWCs

HIV/AIDS, HRSA, NewsBy Amber TynanApril 23, 2025

HRSA Administrator Thomas J. Engels Issues Dear Colleague Letter to RWCs HRSA Administrator Thomas J. Engels issued a letter to Ryan White Clinic HIV/AIDS Program awardees and stakeholders on April 7, 2025. …

Drug Makers Sue HRSA over 340B Participation of Certain STD Clinics

Drug Pricing, HRSA, News, RWC-340BBy Amber TynanDecember 31, 2024

On December 20, 2024, drugmakers Amgen Inc. (Amgen), Eli Lilly and Company (Eli Lilly), and UCB, Inc. (UCB), sued HHS, alleging that HHS has not fulfilled its obligations to oversee…

West Virginia Sides with Drug Manufacturers and Mississippi Rules Against AstraZeneca in State Contract Pharmacy Litigation

HRSA, News, Rulings, RWC-340BBy Amber TynanDecember 31, 2024

To close out the year, two federal judges issued conflicting opinions regarding the likelihood of success in challenges to state 340B contract pharmacy laws.  In the first major siding with…

Sanofi Pauses Rebate Model; Files Lawsuit Against HRSA

HRSA, News, RWC-340BBy Amber TynanDecember 18, 2024

On December 16, Sanofi informed HRSA that it will pause the implementation of its rebate model, termed a “340B credit model.”  The same day, Sanofi filed a lawsuit in the…

HRSA Warns Sanofi Over Proposed Rebate Model; Alludes to Possible Termination of Pharmaceutical Pricing Agreement (PPA)

HRSA, News, RWC-340BBy Amber TynanDecember 16, 2024

On December 13th, the Health Resources and Services Administration (HRSA) issued a letter to Sanofi calling for the manufacturer to cease implementation of its rebate model, which Sanofi terms a…

Bristol-Myers Squibb Sues To Implement Rebate Model; AbbVie Adds Grantees To Its Contract Pharmacy Policy

Drug Pricing, HRSA, News, RWC-340BBy Amber TynanDecember 6, 2024

Bristol-Myers Squibb Sues HHS To Implement 340B Rebate Model On November 26, 2024, Bristol-Myers Squibb (BMS) filed a lawsuit against HRSA in the D.C. District Court to defend its proposed…

Third Lawsuit Is Filed Against HRSA for Blocking the Rebate Model

Drug Pricing, HRSA, News, RWC-340BBy Amber TynanNovember 20, 2024

11/19/2024 – Third Lawsuit Is Filed Against HRSA for Blocking the Rebate Model On November 14, 2024, Eli Lilly and Company (Lilly) filed a lawsuit against HHS and HRSA in…

J&J Sues HHS and HRSA Over HRSA’s Opposition to J&J’s Proposed Rebate Model

Drug Pricing, HHS, HRSA, News, RWC-340BBy Amber TynanNovember 20, 2024

11/14/2024 – J&J Sues HHS and HRSA Over HRSA’s Opposition to J&J’s Proposed Rebate Model On November 12, 2024, Johnson and Johnson Health Care System Inc. (J&J) filed a lawsuit…

J&J Pauses Rebate Model After HRSA Warning  

HRSA, RWC-340BBy Amber TynanOctober 1, 2024

Yesterday, Johnson & Johnson Health Care System Inc. (J&J) stated in a letter to HRSA that it will halt implementation of its proposed rebate model, which was set to take…

Two Covered Entity Hospitals Sue HRSA Over Johnson & Johnson Request for Audit

HRSA, NewsBy Amber TynanJuly 31, 2024

On July 24, 2024, two hospital-covered entities sued the Health Resources and Services Administration (“HRSA”), arguing that HRSA’s approval of J&J’s 340B audit request against them was unlawful and premature. The…

→12345…
67
8→
                                                                            © 2021 Ryan White Clinics for 340B Access. RWC-340B is a 501(c)(4) non-profit corporation.
Go to Top
Translate »
Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset